Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ARDM Aradigm (ARDM) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Aradigm Stock (NASDAQ:ARDM) 30 days 90 days 365 days Advanced Chart Ad Crypto Swap Profits24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But here’s the thing: most people won’t be able to keep up with the pace of the market. That’s why I want to tell you about WaveBot – an automated trading tool created by my good friends Joel and Adam.Register for the FREE Workshop Now & get $10 in Bitcoin Get Aradigm alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.15▼$0.3852-Week Range N/AVolumeN/AAverage Volume97,091 shsMarket Capitalization$761,000.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. Its lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq and Lipoquin that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis, cystic fibrosis, and non-tuberculosis mycobacterium. The company is also developing inhaled ciprofloxacin formulations for treatment of patients with cystic fibrosis, and has tested for the prevention and treatment of inhaled bioterrorism infections, such as Coxiella burnetii or Q fever, inhalation anthrax, tularemia, melioidosis and pneumonic plague. Aradigm Corporation has collaboration agreements with Grifols, S.A. The company was founded in 1991 and is headquartered in Hayward, California.Read More… 24/7 Automated Profits in Crypto (Ad)The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But here’s the thing: most people won’t be able to keep up with the pace of the market. That’s why I want to tell you about WaveBot – an automated trading tool created by my good friends Joel and Adam.Register for the FREE Workshop Now & get $10 in Bitcoin Receive ARDM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aradigm and its competitors with MarketBeat's FREE daily newsletter. Email Address ARDM Stock News HeadlinesFirst International Bank of Israel Ltd (FIBI)November 21, 2023 | investing.comAltshuler Shaham Financial LTD (ALTF)November 10, 2023 | investing.comMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.October 24, 2024 | The Freeport Society (Ad)Non-Cystic Fibrosis Bronchiectasis Market Forecast to 2030May 1, 2023 | marketwatch.comAerodrome Group Ltd (ARDM)April 22, 2023 | investing.comAerodrome Group Ltd (ARDM.TA)March 17, 2023 | finance.yahoo.comHow and Why Google Glass FailedDecember 28, 2022 | investopedia.comSee More Headlines ARDM Stock Analysis - Frequently Asked Questions How were Aradigm's earnings last quarter? Aradigm Co. (NASDAQ:ARDM) announced its earnings results on Thursday, November, 15th. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by $0.03. The firm had revenue of $0.28 million for the quarter. What other stocks do shareholders of Aradigm own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aradigm investors own include Amarin (AMRN), Anavex Life Sciences (AVXL), CRISPR Therapeutics (CRSP), VBI Vaccines (VBIV), Vaxart (VXRT), Aduro Biotech (ADRO) and Altimmune (ALT). Company Calendar Last Earnings11/15/2018Today10/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical Equipment Sub-IndustryN/A Current SymbolNASDAQ:ARDM CUSIPN/A CIK1013238 Webwww.aradigm.com Phone510-265-9000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,700,000.00 Net Margins-374.80% Pretax MarginN/A Return on EquityN/A Return on Assets-374.15% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$14.47 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.83) per share Price / BookN/AMiscellaneous Outstanding Shares15,220,000Free FloatN/AMarket Cap$761,000.00 OptionableOptionable Beta1.57 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report This page (NASDAQ:ARDM) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored #1 Pre-IPO Opportunity For 2024 [Take Action Now!]According to James, the largest IPO in history could kick off in a matter of weeks. I’m talking about Starl...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aradigm Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.